Literature DB >> 9654647

Application of an improved ELISA assay to the analysis of urinary estrogen metabolites.

H L Bradlow1, D W Sepkovic, T Klug, M P Osborne.   

Abstract

Work from Strang and other laboratories has established that the 2-/16 alpha-hydroxyestrone ratio is inversely correlated with the risk for breast and cervical cancer. In order to measure these metabolites in urine samples, it is essential to have an assay for these compounds that is both sensitive and reproducible. The present paper describes such an ELISA assay, which overcomes problems that existed in prior approaches to measuring these compounds. The new ELISA procedure supplies greater sensitivity and reproducibility than earlier assay procedures. The ELISA assay has also been found to correlate well with the GC-MS procedure of Adlercreutz.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654647     DOI: 10.1016/s0039-128x(98)00041-5

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  19 in total

Review 1.  Epidemiologic studies of estrogen metabolism and breast cancer.

Authors:  Regina G Ziegler; Barbara J Fuhrman; Steven C Moore; Charles E Matthews
Journal:  Steroids       Date:  2015-02-26       Impact factor: 2.668

2.  Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.

Authors:  Sally B Coburn; Frank Z Stanczyk; Roni T Falk; Katherine A McGlynn; Louise A Brinton; Joshua Sampson; Gary Bradwin; Xia Xu; Britton Trabert
Journal:  Cancer Causes Control       Date:  2018-12-01       Impact factor: 2.506

3.  Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.

Authors:  Cher M Dallal; Jeffrey A Tice; Diana S M Buist; Douglas C Bauer; James V Lacey; Jane A Cauley; Trisha F Hue; Andrea Lacroix; Roni T Falk; Ruth M Pfeiffer; Barbara J Fuhrman; Timothy D Veenstra; Xia Xu; Louise A Brinton
Journal:  Carcinogenesis       Date:  2013-11-08       Impact factor: 4.944

4.  Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Authors:  Alan A Arslan; Karen L Koenig; Per Lenner; Yelena Afanasyeva; Roy E Shore; Yu Chen; Eva Lundin; Paolo Toniolo; Göran Hallmans; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-27       Impact factor: 4.254

5.  Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism.

Authors:  Cher M Dallal; Louise A Brinton; Charles E Matthews; Ruth M Pfeiffer; Terryl J Hartman; Jolanta Lissowska; Roni T Falk; Montserrat Garcia-Closas; Xia Xu; Timothy D Veenstra; Gretchen L Gierach
Journal:  Med Sci Sports Exerc       Date:  2016-03       Impact factor: 5.411

6.  Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Authors:  Alan A Arslan; Roy E Shore; Yelena Afanasyeva; Karen L Koenig; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

7.  Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.

Authors:  Louise A Brinton; Britton Trabert; Garnet L Anderson; Roni T Falk; Ashley S Felix; Barbara J Fuhrman; Margery L Gass; Lewis H Kuller; Ruth M Pfeiffer; Thomas E Rohan; Howard D Strickler; Xia Xu; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-12       Impact factor: 4.254

8.  Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens.

Authors:  Jessica M Faupel-Badger; Barbara J Fuhrman; Xia Xu; Roni T Falk; Larry K Keefer; Timothy D Veenstra; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

9.  Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.

Authors:  E D Austin; J D Cogan; J D West; L K Hedges; R Hamid; E P Dawson; L A Wheeler; F F Parl; J E Loyd; J A Phillips
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

10.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.